A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Sept. 13, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global...
Company invites individual and institutional investors to attend interactive real-time virtual VirtualInvestorConferences.com ENGLEWOOD, Colo., Sept. 6, 2016 --Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization...
ENGLEWOOD, Colo., Sept. 6, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Chief Operating Officer Jarrett Disbrow will present at the...
Live Conference Call and Webcast Today at 4:30 p.m. ETENGLEWOOD, Colo., Sept. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today a review of...
Live Conference Call and Webcast Scheduled for September 1, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Aug. 25, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...
ENGLEWOOD, Colo., Aug. 18, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at the Rodman & Renshaw 18th Annual Global...
Equity Commitment Supports the U.S. Launch of Natesto® and the Company's Commercial ExpansionENGLEWOOD, Colo., July 28, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU) ("Aytu"), a specialty pharmaceutical company focused on global commercialization of novel products...
ENGLEWOOD, Colo., July 21, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication of the first peer-reviewed journal article...
ENGLEWOOD, Colo., July 13, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the addition of John Donofrio, Jr., a 24-year pharmaceutical...
ENGLEWOOD, Colo., July 7, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented three posters demonstrating the potential of...